Clinical trial
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of…
NCT00192231 · MedImmune LLC, Industry · Completed
Key facts
| NCT number | NCT00192231 |
|---|---|
| Title | Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults Aged 18 and Older |
| Lead sponsor | MedImmune LLC, Industry |
| Collaborators | Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | CAIV-T |
| Enrollment | 120 |
| Start date | Apr 1, 2001 |
| Completion | Jun 1, 2001 |
| First posted | Sep 19, 2005 |
| Last update posted | Sep 13, 2021 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: